chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient received vaccine in afternoon of 12/28. She works in ER as housekeeper 7pm-7am.  The day she received the vaccine she became ill with fever chills and nausea and left work at 2am. On 12/31 she developed hemianopia. She went to ER and they did CT scan. She was told it was complex migraine. She left and came Home. On 1/1/21 her vision was back to normal. On 1/3 she suffered bilateral cerebellum ischemic stroke. She is currently in medical center. In Trauma.
Chest Pain, Shortness of Breathe, Increased Heart Rate, Left Arm numb from shoulder to middle of forearm, Tingling in jaw from ear to ear, Tingling in both right and left hand from wrist down, Tingling in both feet from ankle down. A month later I started to experience nose bleeds. First nose bleed occurred in Oct 2021. Other nose bleeds occurred: Dec 2021, Feb 2022, and Summer of 2022. Patient has encountered some pain around the heart area. At times it is a sharp pain, others are dull and shortness of breath.
pt arm red, sore, swollen, seen 29MAY-arm red, swollen forearm to shoulder;changed to Augmentin;seen 30MAY, 31MAY added prelone;final dx severe inflammatory rxn to DTAP;
Patient presented to have catch up on vaccines. PROQUAD was given instead of MMR, Varicella separately. Patient is 18 years of age, should not have received PROQUAD.
Left shoulder pain, limited range of motion, satus post Naproxen, Voltaren, Flexeril, Ultracet, Prednisone taper and physical therapy interventions. MRI and MRI arthrogram demonstrating bone necrosis and bone marrow edema to greater tubercle of left humerus. Still having pain 6 months later. Referrals to orthopedics, infectious disease.
Mother called stating child has a rash from head to toe.  No blisters, itching or fever and child is acting normal.  Rash appeared approx. 2 hrs after shot.  Advised to take to MD. 1 week follow up, called mother, rash disappeared by next morning and she did not take him to MD.
Patient with racing heart, trembling within 15 minutes.  Blood pressure checked and result was 131/61.  Patient complained of dry mouth and Benadryl administered.  Patient continued to be monitored and within 5 minutes following Benadryl, heart continues to race, chest heaviness, trembling hands, tongue numbness, tongue swelling, slowness of speech and thought.  EpiPen administered to Left thigh.  Within 30 seconds, tongue numbness and swelling resolved.  911 was called and responded to check patient.  Vitals and EKG were monitored.  BP somewhat elevated due to epinephrine.  EKG WNL.  Patient did not go to hospital.
Second vaccine Friday at 9:30 am, felt fine until I went to sleep.   Vomited 24hrs after second dose from extreme dizziness and nausea.   Dizziness (complete spins) when laying down or turning my head to the left to this current day.   Headache in my lower brain cerebellum? area, and behind my eyes all day, for multiple weeks after second dose.   Vertigo feelings and equilibrium feels off still to this current day.   Fourth pregnancy. Estimated due date is January 22, 2021.
He got his vaccine (reported by wife), he told his wife that he was getting dizzy.  Then he started throwing up, but was throwing up blood.  Then he had aches and was feeling bad.  He woke up in the middle of the night with bleeding in the nose and had that for 2-3 days.  He refused to go to the ER in the middle of the night, but he went to the ER the next day.  He was put on allergy relief medicine every 4 hours and also was put on Dexamethasone Sol, Levofloxacin 750 antibiotics.  Since he received the medicine that he got yesterday, but did not want to get the medicine.  She has seen since then that he has improved a little bit, but is tired, does not have the energy that he used to have.  He told his wife that when he went to work he would sleep in the car as he could not manage to work.
PT COMPLAINING PAIN IN UPPER LEFT CHEST (LYMPH PAIN - ) AND SOME PAIN IN LEST SIDE OF NECK -CONSTANT PAIN BECOMES WORSE WHEN LYING DOWN & MOVING LEFT ARM.
Five minutes after injection, felt warmth/flushing spread from top of body down to toes and had trouble breathing.  Symptoms subsided within one to two minutes.  Did not need medication for symptoms to resolve.
Patient received 0.5ML MODERNA dose but should have received PFIZER dose for age group. Per CDC, dose doesn't have to be repeated.
One of 3 injections caused immediate deep shoulder pain, electrical sensation. By next morning, moderate to severe Pain in right shoulder capsule, anterior, significantly decreased range of motion. Pain has gotten worse in 6 days since injections.
Information has been received from a pharmacist concerning a 62 year old female with PENICILLIN allergy who on 05-JAN-2009 was vaccinated with ZOSTAVAX (Oka/Merck) (lot # not reported). On 05-JAN-2009 the patient developed redness at the injection site. The next day (Tuesday), on 06-JAN-2009 the patient had swelling and the reaction was "the size of an egg with tenderness in the area". On Wednesday (07-JAN-2009), "the swelling went down but the area was still tender & red". Today (09-JAN-2009) the area is itchy and swelling is gone." At the time of the report, on 09-JAN-2009, the patient was recovering from the redness and tenderness. It was unspecified if the patient sought medical attention. Additional information has been requested.
typical immune response; injection site was itchy; injection site was more redder; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (typical immune response), VACCINATION SITE PRURITUS (injection site was itchy) and VACCINATION SITE ERYTHEMA (injection site was more redder) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (typical immune response), VACCINATION SITE PRURITUS (injection site was itchy) and VACCINATION SITE ERYTHEMA (injection site was more redder). At the time of the report, VACCINATION COMPLICATION (typical immune response), VACCINATION SITE PRURITUS (injection site was itchy) and VACCINATION SITE ERYTHEMA (injection site was more redder) outcome was unknown.            Concomitant medications were not provided by the reporter.  The reporter denied treatment of the events.    This case was linked to US-MODERNATX, INC.-MOD-2021-076195 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-076195:1st dose case
Pt claims saw floaters at time of injection. Pt was asked to stay for 15 min. Pt called back 30 minutes later and stated he was experiencing numbness of face, forehead and cheek. Directed pt to ER. At ER pt was given BENADRYL and PEPCID.
pt recv vax & devel inj site rxn of redness,swelling,tenderness & a lump.
Patient had persist migraines that have made it so the patient has been  unable to do her daily work and activities.
This is a spontaneous report from a contactable consumer (reporting on herself). A female patient of age 29 unit unspecified received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Batch/lot number and Expired Date: was not reported) via unspecified route of administration, in Feb 2021 as 1st dose, single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Patient received the first dose of the Pfizer-BioNtech COVID-19 vaccine on Monday (Feb 2021), today (Feb 2021) in the morning, she woke up with a rash on her stomach hand wrist. She would like to report the side effect and check if this was probably related to the vaccine. The outcome of the event was unknown. Follow-up attempts have been completed and no further information is expected.
Hard lump about one inch from the injection site. It is red, swollen and hot to the touch. It is also painful when touched. The redness spread the first 24 hours to about the size of a quarter then began to retract with warm compresses, however the size of the hard ball or knot has stayed the same. It's now almost 42 hours later and the redness is still about the size of a dime, it is still hot and swollen as well. The size of the ball remains the same.
10/14/2002 recv'd Td and Flu Vaccine in left deltoid. two days latter arm sore from shoulder to elbow and was swollen and hot from shoulder to elbow. Saw private MD 1/27/2003 and advised her to use hot compresses and to see MD again 4/28/2003.
pt recv vax 2DEC95 & 9DEC95 pt devel a generalized rash,not many pox,on their stomach & face;no further details were provided;
Pt developed welts/ hives.  Uticaria on the MMR administration site (R thigh) as well as R side of face
Patient says she has swelling in her hands, feet and legs. She also states that her right arm felt tight
Patient fainted after receiving the vaccine and fell on the counter. He was back to normal within a minute. He had not had anything to eat since morning. He drank some water and orange juice. He stayed in the pharmacy for 30 minutes and was ok when he left.
Reactions: arm pain, arm swelling, fever low grade, fatigue, myalgias, arthralgias. lasted till 6 pm 1/05/21.
Patient was accidentally given a half dose (0.25ml) of Moderna even though she should have had 0.5ml since it was her first COVID vaccine. We contacted the patient the next day and were able to vaccinate her with a full 0.5ml dose of Moderna (same lot #). There was no apparent adverse event.
MEDICATION ERROR,  0.5ML WAS GIVEN INSTEAD OF 0.25 FOR BOOSTER.
Nausea, emesis, dizziness, pallor. Immediately placed in supine position & raised legs. Provided cool cloth to head & offered water to drink. BP 92/60, HR 80. Continued to monitor for 30 minutes until pt improved to pre-vaccination status.
Muscle spasms in chest and back; continued several days until actual shingles rash appeared on 01/17/2014; Began treatment on that day for shingles.
Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Mar-2021 at 11:51 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 30-Mar-2021 at 11:51 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). In 2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Age of patient was reported as 68.02 for dose administered on 30-Mar-2021.  No concomitant medications were reported.  Batch number 019B21A underwent temperature excursion on 30-Mar-2021 with temperature 33 degrees Fahrenheit at 09:00 AM. This vial was moved to fridge on 23-Mar-2021 and beyond use date for the vial was reported as 22-Apr-2021. Product moved to clinic on 30-Mar-2021. Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination at around 2021. Vials were only punctured right before administration. Vaccines were not frozen at time of administration. It was reported that each time a vial was put into a cooler, sometimes there was a period of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34- or 35-degree Fahrenheit. Temperature recordings were taken using a traceable temperature monitor at every hour.   No treatment medications were reported.   This case was linked to MOD-2022-566976 (Patient Link).
Patient administered vaccine after the manufacture's date of expiration; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient administered vaccine after the manufacture's date of expiration) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Oct-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient administered vaccine after the manufacture's date of expiration). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient administered vaccine after the manufacture's date of expiration) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported.  The vial did not undergo any temperature excursions. Date the vial initially stored in the refrigerator was unknown.  Treatment medications were not reported.   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2022: Follow up received reporter's address updated.
L deltoid hard, red and hot ~ 2 to 2.5 inches x 4 to 4.5 inches, fatigue, body aches.
fever, piercing screaming fits that last for hours, swollen leg and red bump at injection sight. This started within 2 hrs of the vaccination.  At 17 months old, patient was diagnosed with speech delays and qualified for speech therapy through Early Intervention. He received 2 hour long speech therapy sessions that lasted until his 3rd birthday.
Eye irritation; Very large puffing eye that I could not open; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: EYE IRRITATION (non-serious), outcome "unknown", described as "Eye irritation"; EYE DISORDER (non-serious), outcome "unknown", described as "Very large puffing eye that I could not open". The events "eye irritation" and "very large puffing eye that i could not open" were evaluated at the physician office visit. Therapeutic measures were taken as a result of eye irritation, eye disorder.  Additional information: The patient received 1st shot and within 7 days started experiencing eye irritation. The patient's physician was very curious he had 2 patients in 2 hours with the same thing. Later that week I received an article about this same issue being studied in withheld.  Follow-up (18Feb2022): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202200073209 same reporter/drug/event, different patient;US-PFIZER INC-202200073160 same reporter/drug/event, different patient
Migraine; shingles; could not eat; Could not stand a few days after vaccine; rash; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of MIGRAINE (Migraine), HERPES ZOSTER (shingles), FEEDING DISORDER (could not eat), HYPOKINESIA (Could not stand a few days after vaccine) and RASH (rash) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included VALACICLOVIR HYDROCHLORIDE (VALTREX) for an unknown indication.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MIGRAINE (Migraine), HERPES ZOSTER (shingles), FEEDING DISORDER (could not eat), HYPOKINESIA (Could not stand a few days after vaccine) and RASH (rash). At the time of the report, MIGRAINE (Migraine), HERPES ZOSTER (shingles), FEEDING DISORDER (could not eat), HYPOKINESIA (Could not stand a few days after vaccine) and RASH (rash) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In February 2021, Herpes zoster: diagnosed with shingles on 2 or 3 Feb 2021.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
pt recv vax 930AM in school clinic came to clinic 1245PM w/raised, reddened, hive-like rash on arms, legs & trunk, face red w/raised areas; no other sx; parent called family MD PDH advised; father reported on 1MAY95 rash much improved;
slightly sore arm at the injection site; This case was reported by a consumer via interactive digital media and described the occurrence of injection site pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was unknown.   It was unknown if the reporter considered the injection site pain to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 16-SEP-2022 Reporter's Comment: This case was reported by the patient via interactive digital media. The patient received a dose of Shingles vaccine into unknown arm and experienced slightly sore arm at the injection site.  Additional Supportive Information: The follow-up would not possible as no contact details were available.
Information has been received from a health professional concerning a 39 month old white male with a peach allergy who on 10-AUG-2004 was vaccinated in the left upper arm with a first dose of Varivax (lot # 645575/0436N) (diluent (lot # 646509/0516N). There was no illness at the time of vaccination. On 10-OCT-2006 the patient presented to the physician's office with an outbreak of chickenpox, actual onset date not reported. At the time of the report the patient's recovery status was unknown. No further information was available. Additional information has been requested. The patient's sister (WAES # 0610USA10406) had a similar experience following vaccination.
This spontaneous report as received from a registered nurse refers to a patient of unknown demographics. The patient's concurrent conditions, medical history, drug reactions/allergies and concomitant therapy were not reported. On 19-JUL-2018, the patient was vaccinated with improperly stored doses of PROQUAD either from lot # R002939, expiry date: 29-JUL-2019 or lot # R006218, expiry date: 28-AUG-2019 (dose, frequency and route were not reported) for prophylaxis. Sterile diluent (MRK INJ) was properly stored. No adverse effects were reported. No product quality complaint was involved. The PROQUAD was stored in temperature of 15 degree Fahrenheit (F) to 46 F for 14 hours on 16-JUN-2018. No previous temperature excursion was reported. A digital data logger was involved. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1808USA001261: US-009507513-1808USA004381:Original Case : 1808USA001261; US-009507513-1808USA004382:Original Case : 1808USA001261; US-009507513-1808USA004383:Original Case : 1808USA001261; US-009507513-1808USA004384:Original Case : 1808USA001261; US-009507513-1808USA004380:Original Case : 1808USA001261; US-009507513-1808USA004379:Original Case : 1808USA001261; US-009507513-1808USA004376:Original Case : 1808USA001261; US-009507513-1808USA004377:Original Case : 1808USA001261; US-009507513-1808USA004378:Original Case : 1808USA001261; US-009507513-1808USA004385:Original Case : 1808USA001261; US-009507513-1808USA004386:Original Case : 1808USA001261; US-009507513-1808USA004388:Original Case : 1808USA001261; US-009507513-1808USA004362:Original Case : 1808USA001261; US-009507513-1808USA004363:Original Case : 1808USA001261; US-009507513-1808USA004364:Original Case : 1808USA001261; US-009507513-1808USA004389:Original Case : 1808USA001261; US-009507513-1808USA004390:Original Case : 1808USA001261; US-009507513-1808USA004391:Original Case : 1808USA001261; US-009507513-1808USA004392:Original Case : 1808USA001261; US-009507513-1808USA004393:Original Case : 1808USA001261; US-009507513-1808USA004394:Original Case : 1808USA001261; US-009507513-1808USA004395:Original Case : 1808USA001261; US-009507513-1808USA004396:Original Case : 1808USA001261; US-009507513-1808USA004365:Original Case : 1808USA001261; US-009507513-1808USA004366:Original Case : 1808USA001261; US-009507513-1808USA004367:Original Case : 1808USA001261; US-009507513-1808USA004397:Original Case : 1808USA001261; US-009507513-1808USA004398:Original Case : 1808USA001261; US-009507513-1808USA004399:Original Case : 1808USA001261; US-009507513-1808USA004368:Original Case : 1808USA001261; US-009507513-1808USA004369:Original Case : 1808USA001261; US-009507513-1808USA004400:Original Case : 1808USA001261; US-009507513-1808USA004401:Original Case : 1808USA001261; US-009507513-1808USA004370:Original Case : 1808USA00126.
Itchy rash, small red bumps on legs, arms. From 2 days after vaccination, for 6+ days. Less itching after 4 days but rash still spread to hips , back and neck. Benedryl and Hydrocortizone cream. After seeing doctor, Zyrtec (OTC) and Triamcinolone Acetonide Ointment
Feverish feeling with body temperature change of about 1 degree that lasted for about 6 hours on 3/14/2021. Skin rash developed at the same time across face, neck and chest. Skin rash was not hives, but small pimple-like bumps. The rash lasted for about 7-8 days, with the 7th day starting to see the rash recede.
Around 6 am - approximately 11 hours after receiving my shot, I had developed a low grade fever of around 99.5 degrees (my baseline is always around 97). I was achy and had chills most of the day and very fatigued. The low grade fever persisted throughout the day, highest reaching 99.9. I took Advil every four hours and went to sleep around 9:30 pm, I was mostly 100% better by Saturday morning with the exception of a little residual fatigue.
(I am unsure about which meningococcal vaccine was given, and the clinic could not verify at this time. But it was her second in the series). The meningococcal vaccine was given first, followed by HAVRIX. Within 2 minutes, patient started feeling dizzy and said she was "seeing stars". Her mother was with her, and sat her down in a chair. Patient then quickly slumped over, her eyes rolled back, her arms went stiff, and she began to convulse (lasting probably less than a minute).  After coming around, patient noted that her hands were tingly and she felt hot. Her skin appeared grey. The staff quickly attended to her, and took her blood pressure (which was just a little lower than at the beginning of her appointment, and check her blood sugar, which was normal. The staff gave her crackers and orange juice, and provided instructions for what to watch for over the next 24-48 hours. Patient has no known medical conditions and has never had a seizure prior to today.
23MAR99 50-75 vesicular lesions onset in AM;afeb;24MAR99 inc temp vesicular lesions still erupting;dx breakthrough varicella;